There are 3158 resources available
CDK4/6 inhibitors for early breast cancer: State-of-the-art
Presenter: Stephen Johnston
Session: Incorporating novel treatment insights for ER+ early BC patients
Resources:
Slides
Webcast
LBA66 - UpFrontPSMA: A randomised phase II study of sequential 177Lu-PSMA-617 and docetaxel (D) versus docetaxel in metastatic hormone-sensitive prostate cancer (mHSPC)
Presenter: Arun Azad
Session: Proffered paper session: GU tumours, prostate
Resources:
Abstract
Slides
Webcast
502O - Pembrolizumab in combination with CAPOX and bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: Preliminary results of FFCD 1703 POCHI trial
Presenter: David Tougeron
Session: Proffered paper session 2: GI tumours, lower
Resources:
Abstract
Slides
Webcast
LBA27 - First-in-human results of STX-478, a mutant-selective PI3Ka inhibitor, in advanced solid tumor patients
Presenter: Alberto Montero
Session: Proffered paper session 2: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
715MO - Safety and efficacy of sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated advanced endometrial carcinoma (EC) and ovarian cancer (OC) from a phase II study
Presenter: Danbo Wang
Session: Mini oral session 2: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
LBA44 - Pembrolizumab vs ipilimumab in advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study
Presenter: Caroline Robert
Session: Mini oral session: Melanoma and other skin tumours
Resources:
Abstract
Webcast
Renal-cell carcinoma: Discussion
Presenter: Thomas Powles
Session: ESMO Clinical Practice Guidelines 2
Resources:
Slides
Webcast
The gut microbiota & immune related adverse events
Presenter: Christina Ruhlmann
Session: ESMO in collaboration with the MASCC: Shedding light on the hidden microbiota
Resources:
Slides
Webcast
Real world experience & patients' participation in multidisciplinary consortiums
Presenter: Bettina Ryll
Session: The future of cancer via patient expertise in research & innovation projects
Resources:
Slides
Webcast
CAR NK cells
Presenter: Katy Rezvani
Session: Gene modified T cells and new players
Resources:
Slides
Webcast